Cluster 1 (rapidly increasing TyG) likely reflects progressive dysregulation of LPL-mediated triglyceride clearance or elevated ANGPTL3/4/8 expression, promoting atherogenic lipoprotein accumulation and endothelial dysfunction (20, 30). The gene discussed is LPL; the disease is endothelial dysfunction.